Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes

The present study describes the development of DNA vaccines using the hemagglutinin-neuraminidase (HN) and fusion (F) genes from AF2240 Newcastle disease virus strain, namely pIRES/HN, pIRES/F and pIRES-F/HN. Transient expression analysis of the constructs in Vero cells revealed the successful expre...

Full description

Bibliographic Details
Main Authors: Firouzamandi, Masoumeh, Moeini, Hassan, Hosseini, Davood, Bejo, Mohd Hair, Omar, Abdul Rahman, Mehrbod, Parvaneh, Ideris, Aini
Format: Article
Language:English
Published: The Korean Society of Veterinary Science 2016
Online Access:http://psasir.upm.edu.my/id/eprint/54518/1/Improved%20immunogenicity%20of%20Newcastle%20disease%20virus%20inactivated%20vaccine%20.pdf
_version_ 1796976097980579840
author Firouzamandi, Masoumeh
Moeini, Hassan
Hosseini, Davood
Bejo, Mohd Hair
Omar, Abdul Rahman
Mehrbod, Parvaneh
Ideris, Aini
author_facet Firouzamandi, Masoumeh
Moeini, Hassan
Hosseini, Davood
Bejo, Mohd Hair
Omar, Abdul Rahman
Mehrbod, Parvaneh
Ideris, Aini
author_sort Firouzamandi, Masoumeh
collection UPM
description The present study describes the development of DNA vaccines using the hemagglutinin-neuraminidase (HN) and fusion (F) genes from AF2240 Newcastle disease virus strain, namely pIRES/HN, pIRES/F and pIRES-F/HN. Transient expression analysis of the constructs in Vero cells revealed the successful expression of gene inserts in vitro. Moreover, in vivo experiments showed that single vaccination with the constructed plasmid DNA (pDNA) followed by a boost with inactivated vaccine induced a significant difference in enzyme-linked immunosorbent assay antibody levels (p < 0.05) elicited by either pIRES/F, pIRES/F+ pIRES/HN or pIRES-F/HN at one week after the booster in specific pathogen free chickens when compared with the inactivated vaccine alone. Taken together, these results indicated that recombinant pDNA could be used to increase the efficacy of the inactivated vaccine immunization procedure.
first_indexed 2024-03-06T09:20:54Z
format Article
id upm.eprints-54518
institution Universiti Putra Malaysia
language English
last_indexed 2024-03-06T09:20:54Z
publishDate 2016
publisher The Korean Society of Veterinary Science
record_format dspace
spelling upm.eprints-545182020-05-28T04:23:25Z http://psasir.upm.edu.my/id/eprint/54518/ Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes Firouzamandi, Masoumeh Moeini, Hassan Hosseini, Davood Bejo, Mohd Hair Omar, Abdul Rahman Mehrbod, Parvaneh Ideris, Aini The present study describes the development of DNA vaccines using the hemagglutinin-neuraminidase (HN) and fusion (F) genes from AF2240 Newcastle disease virus strain, namely pIRES/HN, pIRES/F and pIRES-F/HN. Transient expression analysis of the constructs in Vero cells revealed the successful expression of gene inserts in vitro. Moreover, in vivo experiments showed that single vaccination with the constructed plasmid DNA (pDNA) followed by a boost with inactivated vaccine induced a significant difference in enzyme-linked immunosorbent assay antibody levels (p < 0.05) elicited by either pIRES/F, pIRES/F+ pIRES/HN or pIRES-F/HN at one week after the booster in specific pathogen free chickens when compared with the inactivated vaccine alone. Taken together, these results indicated that recombinant pDNA could be used to increase the efficacy of the inactivated vaccine immunization procedure. The Korean Society of Veterinary Science 2016 Article PeerReviewed text en http://psasir.upm.edu.my/id/eprint/54518/1/Improved%20immunogenicity%20of%20Newcastle%20disease%20virus%20inactivated%20vaccine%20.pdf Firouzamandi, Masoumeh and Moeini, Hassan and Hosseini, Davood and Bejo, Mohd Hair and Omar, Abdul Rahman and Mehrbod, Parvaneh and Ideris, Aini (2016) Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes. Journal of Veterinary Science, 17 (1). pp. 21-26. ISSN 1229-845X; ESSN: 1976-555X https://vetsci.org/search.php?where=aview&id=10.4142/jvs.2016.17.1.21&code=0118JVS&vmode=AONLY 10.4142/jvs.2016.17.1.21
spellingShingle Firouzamandi, Masoumeh
Moeini, Hassan
Hosseini, Davood
Bejo, Mohd Hair
Omar, Abdul Rahman
Mehrbod, Parvaneh
Ideris, Aini
Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes
title Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes
title_full Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes
title_fullStr Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes
title_full_unstemmed Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes
title_short Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes
title_sort improved immunogenicity of newcastle disease virus inactivated vaccine following dna vaccination using newcastle disease virus hemagglutinin neuraminidase and fusion protein genes
url http://psasir.upm.edu.my/id/eprint/54518/1/Improved%20immunogenicity%20of%20Newcastle%20disease%20virus%20inactivated%20vaccine%20.pdf
work_keys_str_mv AT firouzamandimasoumeh improvedimmunogenicityofnewcastlediseasevirusinactivatedvaccinefollowingdnavaccinationusingnewcastlediseasevirushemagglutininneuraminidaseandfusionproteingenes
AT moeinihassan improvedimmunogenicityofnewcastlediseasevirusinactivatedvaccinefollowingdnavaccinationusingnewcastlediseasevirushemagglutininneuraminidaseandfusionproteingenes
AT hosseinidavood improvedimmunogenicityofnewcastlediseasevirusinactivatedvaccinefollowingdnavaccinationusingnewcastlediseasevirushemagglutininneuraminidaseandfusionproteingenes
AT bejomohdhair improvedimmunogenicityofnewcastlediseasevirusinactivatedvaccinefollowingdnavaccinationusingnewcastlediseasevirushemagglutininneuraminidaseandfusionproteingenes
AT omarabdulrahman improvedimmunogenicityofnewcastlediseasevirusinactivatedvaccinefollowingdnavaccinationusingnewcastlediseasevirushemagglutininneuraminidaseandfusionproteingenes
AT mehrbodparvaneh improvedimmunogenicityofnewcastlediseasevirusinactivatedvaccinefollowingdnavaccinationusingnewcastlediseasevirushemagglutininneuraminidaseandfusionproteingenes
AT iderisaini improvedimmunogenicityofnewcastlediseasevirusinactivatedvaccinefollowingdnavaccinationusingnewcastlediseasevirushemagglutininneuraminidaseandfusionproteingenes